248 related articles for article (PubMed ID: 15007620)
1. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation.
Nicolau C; Catalá V; Vilana R; Gilabert R; Bianchi L; Solé M; Pagés M; Brú C
Eur Radiol; 2004 Jun; 14(6):1092-9. PubMed ID: 15007620
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced ultrasound of hepatocellular carcinoma: correlation between enhancement pattern and cellular differentiation on histopathlogy.
Loria F; Loria G; Basile S; Crea G; Randazzo D; Frosina L
Updates Surg; 2012 Dec; 64(4):247-55. PubMed ID: 23055349
[TBL] [Abstract][Full Text] [Related]
3. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
4. Correlation between SonoVue enhancement in CEUS, HCC differentiation and HCC diameter: analysis of 130 patients with hepatocellular carcinoma (HCC).
von Herbay A; Vogt C; Westendorff J; Häussinger D; Gregor M
Ultraschall Med; 2009 Dec; 30(6):544-50. PubMed ID: 19998208
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas--correlation with histological differentiation.
Strobel D; Kleinecke C; Hänsler J; Frieser M; Händl T; Hahn EG; Bernatik T
Ultraschall Med; 2005 Aug; 26(4):270-6. PubMed ID: 16123920
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of contrast-enhanced ultrasound washout rate in predicting hepatocellular carcinoma differentiation.
Feng Y; Qin XC; Luo Y; Li YZ; Zhou X
Ultrasound Med Biol; 2015 Jun; 41(6):1553-60. PubMed ID: 25747937
[TBL] [Abstract][Full Text] [Related]
7. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O
AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852
[TBL] [Abstract][Full Text] [Related]
9. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
10. Enhancement patterns of small hepatocellular carcinoma (≤ 30 mm) on contrast-enhanced ultrasound: Correlation with clinicopathologic characteristics.
Fan PL; Ding H; Mao F; Chen LL; Dong Y; Wang WP
Eur J Radiol; 2020 Nov; 132():109341. PubMed ID: 33069987
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.
Bohle W; Clemens PU; Heubach T; Zoller WG
Ultraschall Med; 2012 Dec; 33(7):E191-E195. PubMed ID: 22194045
[TBL] [Abstract][Full Text] [Related]
12. Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid®.
Ren J; Lu Q; Fei X; Dong Y; D Onofrio M; Sidhu PS; Dietrich CF
Eur Radiol; 2024 Jun; 34(6):3795-3812. PubMed ID: 37989916
[TBL] [Abstract][Full Text] [Related]
13. [Early diagnosis of small hepatocellular carcinoma by new contrast-enhanced ultrasound technique].
Chen MH; Dai Y; Yan K; Fan ZH; Wu W; Wang YB; Yin SS; Yang W; Li JY
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):458-62. PubMed ID: 16224512
[TBL] [Abstract][Full Text] [Related]
14. High mechanical index post-contrast ultrasonography improves tissue structural display of hepatocellular carcinoma.
Chen MH; Yang W; Dai Y; Wu W
Chin Med J (Engl); 2005 Dec; 118(24):2046-51. PubMed ID: 16438901
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology.
Fan ZH; Chen MH; Dai Y; Wang YB; Yan K; Wu W; Yang W; Yin SS
AJR Am J Roentgenol; 2006 Jun; 186(6):1512-9. PubMed ID: 16714638
[TBL] [Abstract][Full Text] [Related]
16. Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.
Bernatik T; Seitz K; Blank W; Schuler A; Dietrich CF; Strobel D
Ultraschall Med; 2010 Dec; 31(6):577-81. PubMed ID: 20740399
[TBL] [Abstract][Full Text] [Related]
17. Differential Diagnosis of Arterial Phase Enhanced Hepatic Inflammatory Lesions and Hepatocellular Carcinomas with Contrast-enhanced Ultrasound.
Yang W; Yan K; Wang S; Dai Y; Wu W; Yin SS; Chen MH
Ultrasound Med Biol; 2016 Jan; 42(1):82-91. PubMed ID: 26456578
[TBL] [Abstract][Full Text] [Related]
18. Perfusion Characteristics of Hepatocellular Carcinoma at Contrast-enhanced Ultrasound: Influence of the Cellular differentiation, the Tumor Size and the Underlying Hepatic Condition.
Yang D; Li R; Zhang XH; Tang CL; Ma KS; Guo DY; Yan XC
Sci Rep; 2018 Mar; 8(1):4713. PubMed ID: 29549368
[TBL] [Abstract][Full Text] [Related]
19. Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma.
Martie A; Sporea I; Popescu A; Sirli R; Dănilă M; Serban C; Ardelean M; Bota S; Sendroiu M; Chisevescu D
Med Ultrason; 2011 Jun; 13(2):108-13. PubMed ID: 21655536
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images.
Korenaga K; Korenaga M; Furukawa M; Yamasaki T; Sakaida I
J Gastroenterol; 2009; 44(7):733-41. PubMed ID: 19387532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
